French | English

Home : R&D > Projects

Development product portfolio

BioAlliance Pharma places intellectual property at the heart of its activities and develops a proactive “Intellectual Property” strategy that is directly linked to its research and development projects.

At the end of 2009, the product portfolio is protected by 30 families of published patents, including 320 patent applications and patents of which over 67% have been issued.